A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell–dependent murine model of allergic asthma-Reference-Cited by-同舟云学术

A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell–dependent murine model of allergic asthma

Published:2013-02 Issue:2 Volume:131 Page:501-511.e1
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Price Megan M.,Oskeritzian Carole A.,Falanga Yves T.,Harikumar Kuzhuvelil B.,Allegood Jeremy C.,Alvarez Sergio E.,Conrad Daniel,Ryan John J.,Milstien Sheldon,Spiegel Sarah

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference46 articles.

1. The many paths to asthma: phenotype shaped by innate and adaptive immunity;Kim;Nat Immunol,2010

2. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity;Galli;Nat Rev Immunol,2008

3. The alliance of sphingosine-1-phosphate and its receptors in immunity;Rivera;Nat Rev Immunol,2008

4. The outs and the ins of sphingosine-1-phosphate in immunity;Spiegel;Nat Rev Immunol,2011

5. Sphingosine-1-phosphate aggravates antigen-induced airway inflammation in mice;Chiba;Open Respir Med J,2010

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heavy Metal Exposure-Mediated Dysregulation of Sphingolipid Metabolism;Antioxidants;2024-08-12

2. Orally administered yeast‐derived β‐glucan alleviates mast cell‐dependent airway hyperresponsiveness and inflammation in a murine model of asthma;Immunity, Inflammation and Disease;2024-06

3. Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy;Cell Communication and Signaling;2024-05-02

4. Bronchoconstriction damages airway epithelia by crowding-induced excess cell extrusion;Science;2024-04-05

5. Bergapten inhibits airway inflammation and MRGPRX2-mediated mast cells activation by targeting NR4A1;International Immunopharmacology;2024-03